Broken Coast Cannabis Launches Full Spectrum ‘woah’

2 years ago

A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across…

Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism

2 years ago

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer…

INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer

2 years ago

In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab…

Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives

2 years ago

mRNA Diagnostic Index to Measure Drug Treatment ResponseVancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Nova Mentis Life Science…

CBD of Denver Accelerates Expansion Plans with Strategic Priorities Set for Second Half of 2022

2 years ago

Denver, Colorado--(Newsfile Corp. - June 16, 2022) -  CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and…

Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the…

Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer

2 years ago

 Innovative physician leader brings over 20 years of experience to Biote’s executive team IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the…

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

2 years ago

Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease The Innovation…

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

2 years ago

The long-term implantable E3 CGM system now approved for commercialization in select European markets GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE…

Encision Reports Fourth Quarter Fiscal Year 2022 Results

2 years ago

BOULDER, CO / ACCESSWIRE / June 16, 2022 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode…